Mycea
Develops fungal-extract crop protection candidates for agricultural and biocontrol partners
Highlights
- New on EvolcAdded 2026-10-30
About Mycea
Mycea develops natural crop protection solutions from wild forest fungi. Its discovery platform screens fungal extracts and advances candidates through field validation toward regulatory filing.
The company works with industrial partners on multi-site field trials and is focused on biocontrol for international markets. It uses machine learning and predictive modelling to support discovery and production optimisation.
Founded in 2018 in Montpellier, France, Mycea has a 20–49 employee band. Its team includes 15 dedicated talents; its commercial spin-off Amoterra became independent in 2025.
Product: A discovery platform and pipeline of natural crop protection candidates derived from wild fungal extracts.
Jobs at Mycea
Leadership
- Aline Bsaibes · CEO - Business & PartnershipsSource: company website
- Dominique Barry Etienne · Founder | CEO - Science & TechSource: company website
More biotech & pharma companies
Naemos
Plant-based cosmetic active ingredients from indoor-farmed microgreens and eco-extraction, sold to cosmetic brandsYoung companyNew on EvolcNanobiotix
Physics-based nanotherapeutics for cancer, with lead candidate NBTXR3 in clinical development with JanssenNew on EvolcNaobios
GMP contract development and manufacturing of viral vaccines, vectors and other virus-based products for biotech and pharmaceutical sponsorsNew on EvolcRemote-friendlyNeuro-Sys
Preclinical neuroscience research services for pharmaceutical, biotech and academic organizations developing CNS and PNS therapiesNew on EvolcNG Biotech
Rapid in vitro diagnostic tests for healthcare professionals, patients and global partnersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Complianz
- Elementor
- Google reCAPTCHA
- PHP
- WordPress
- jQuery